Speaker 1: Bloomberg Audio Studios, Podcasts, Radio News.
Speaker 2: The Stock Movers Report, your roundup of companies making moves
Speaker 2: in the stock market, harnessing the power of Bloomberg Data.
Speaker 1: I'm Jim Steneveec along with Carol Master. Let's take a
Speaker 1: look at some stocks on the move today with us
Speaker 1: as Bloomberg News Cross Asset reporter Isabel Lee. Isabelle. A
Speaker 1: lot of stocks moving today. One to the upside, Eli Lilly.
Speaker 3: We have to talk about Eli Lilly. So the stock
Speaker 3: was hired by around three percent. Now it's paired by
Speaker 3: some of those games, but still up by one and
Speaker 3: a half percent. So investors are cheering a next generation
Speaker 3: obesity shot that helps patients lose as much as twenty
Speaker 3: three percent of their body weights a lot. I know,
Speaker 3: I was computing in my head and I was like,
Speaker 3: that is a lot.
Speaker 4: It's a lot.
Speaker 3: No matter how much you weigh, that is a lot. Yeah,
Speaker 3: And this could potentially make the experimental drug the most
Speaker 3: potent weight loss medicine yet. So patients on the highest
Speaker 3: dose of the drug lost nearly a quarter over the
Speaker 3: weight in sixty eight weeks, so that's more than a year.
Speaker 3: And the study participants experience a sixty two percent reduction
Speaker 3: in knee pain. And I was talking to an author
Speaker 3: of the story at Madison Muller and I was telling
Speaker 3: her that, you know, when you think about weight loss,
Speaker 3: people usually associated with superficiality or looks, but it actually
Speaker 3: really helps people who have medical problems, and it can
Speaker 3: help you with your lifestyle improvement and just overall make
Speaker 3: you healthier. And why is this a big deal Because
Speaker 3: the obesity market is expected to hit around one hundred
Speaker 3: billion dollars by twenty thirty, which is massive.
Speaker 4: I mean, listen, we have just talked about how overweight
Speaker 4: the American population is and diabetes. How many Americans are
Speaker 4: either pre diabetic or diabetic. It's a large proportion, I
Speaker 4: want to say, like forty or fifty percent of our
Speaker 4: population easily. And so if you think about what this
Speaker 4: can do in terms of for some people who are
Speaker 4: having a hard time losing weight who are diabetic, this
Speaker 4: can be a game changer. And we kid with madisone
Speaker 4: all the time, like is this the drug that's going
Speaker 4: to fix all that ailss? But it kind of gets
Speaker 4: down to that point that it being overweight is I
Speaker 4: know it's hard for some people in terms of weight management.
Speaker 4: But it is a much healthier thing to be is
Speaker 4: not be overweight.
Speaker 3: Yes, the ticker is Lly and the company's shot that
Speaker 3: zep bound is alth I did a most popular But
Speaker 3: of course Lily is trying to develop and raising develop
Speaker 3: drugs that are more effective, and the competition there is
Speaker 3: also intense.
Speaker 1: I was looking at Yeah, what are you looking at?
Speaker 4: Over thirty eight million Americans have diabetes roughly one intent.
Speaker 4: So it's not maybe.
Speaker 3: Look up good job. That's a lot of.
Speaker 4: Silly little thing called Google.
Speaker 3: Yeah, not chat, GPTWO.
Speaker 1: No, I didn't get there. I didn't get there.
Speaker 4: But it says over one point three billion. This is
Speaker 4: a Bloomberg story. Actually this is a couple of years ago.
Speaker 4: Over one point three billion globally will have diabetes by
Speaker 4: twenty to fifty. So that's a lot of folks. All right,
Speaker 4: So Eli, Lilly a gainer.
Speaker 1: What about Gemini space station the fintech firm.
Speaker 3: This is a big gainer up by twenty five percent.
Speaker 3: So Gemini, when you think about it, where you're a
Speaker 3: crypto show, why oh nothing.
Speaker 4: Because I have to do gainers. But I should have
Speaker 4: done this one anyway, Go.
Speaker 3: Ahead and Carol, it's twenty five percent.
Speaker 1: You get to say Gemini space station exactly.
Speaker 3: So, Tim, who is the crypto show, you would know
Speaker 3: that when you hear Gemini, you think it's like a
Speaker 3: crypto exchange. But then no, of course they're trying to
Speaker 3: also muscle their way into the fast moving field of
Speaker 3: prediction markets.
Speaker 1: I knew you were going to say that they can't.
Speaker 3: They their application for a derivative exchange was approved better
Speaker 3: c of TC, so now they're clearly expanding and according
Speaker 3: to their website, it will allow soon existing u AS
Speaker 3: customers to trade events contract And this is interesting because
Speaker 3: increasingly cryptonated firms like poly market have been straddling digital
Speaker 3: assets prediction markets. Now a lot are trying to do both,
Speaker 3: and many firms have really expressed interest in this.
Speaker 1: I want to know when they're going to build the
Speaker 1: space station.
Speaker 4: Yspace station ticker g E M I why are they
Speaker 4: Semini space station?
Speaker 1: I still think of it as being called Gemini, but
Speaker 1: the official name is Gemini Space winkle loss.
Speaker 3: Yeah, right, some people should winkle y because it's the
Speaker 3: plural of winkle monkele pize.
Speaker 4: Can I just say forty two percent of the float
Speaker 4: is short on this puppy. Oh, so that's a little
Speaker 4: bit of negative since just gonna put that out there,
Speaker 4: even though it's flying high today, Oracle not flying high today.
Speaker 3: Not flying high. Down by ten percent, that's I think
Speaker 3: the most since at least January, erasing more than one
Speaker 3: hundred billion dollars in market value, and at one point
Speaker 3: was on track to close with its steepest one day
Speaker 3: drop since two thousand and one.
Speaker 4: It's a long time twenty four years ago.
Speaker 3: So again this comes after, of course, the company said
Speaker 3: that its capital expenditure is about to reach fifty billion
Speaker 3: dollars by the end of the fiscal year ending in
Speaker 3: May twenty twenty six. Annual revenue will be around sixty
Speaker 3: seven billion dollars. So this is interesting because again it's
Speaker 3: like AI hopes and dreams. I've talked to some analysts
Speaker 3: and they were like, Oracle gave investors everything they want
Speaker 3: on paper, but of course you still hope for more
Speaker 3: and more. And cloud sales increased Acid revenue, but both
Speaker 3: fell short of estimates, and the latest support just really
Speaker 3: makes you think of the reversal fortunes of Oracle, which
Speaker 3: earlier this year was just having a blistering rally. Remember
Speaker 3: its co founder Larry Ellison was at one point the
Speaker 3: richest men Honors, richer than Elon Musk. Yeah, but now
Speaker 3: we're seeing shares down by ten percent. Ticker is ourcl.
Speaker 2: The stock moover's report from Bloomberg Radio. Check back with
Speaker 2: us throughout the day for the latest roundup of companies
Speaker 2: making news on Wall Street and for the latest market
Speaker 2: moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube,
Speaker 2: Bloomberg dot com, and on Applecarplay and Android Auto with
Speaker 2: the Bloomberg Business app.